MODERNA to test COVID-19 vaccine on infants as young as 6 months old
Robert Gorter, MD, PhD.
November 11th, 2021
Biotechnology company Moderna Therapeutics will soon begin large-scale testing of its COVID-19 vaccine on infants.
The vaccine clinical trial, called KidCOVE, is being carried out in the USA at 79 locations across 13 states and will involve roughly 13,275 participants between the ages of 6 months and 11 years old in its entirety.
The first phase — which has already been completed — involved children between the ages of 6 years to less than 12 years old. The study is now reportedly in its second phase, during which children between the ages of 2 years to less than 6 years old will undergo testing. The third and final stage will test the vaccine on children ages 6 months to less than 2 years old.